Yoris, like most people, was shocked at the results of the research.

So I expected that the heritability of Livestream would be a bit bigger than originally estimated when we really kind of would model it a bit better.

But I didn't expect it would jump from, say, 20% to almost 50%.

I think that the jump was, for me, the biggest surprise.

The fact that it was more heritable when we adjusted in the models, at least for extrinsic mortality, was not unexpected.

But the amount by which it jumped, that was actually quite surprising for me.

Is that something that could come into play here?

I think CRISPR editing is very valuable for specific genetic diseases where there is a mutation that you want to remove and that will give you later on the benefit, say something like sickle cell disease, or if you can do it at a specific location where it's important that a gene is restored.